Results 201 to 210 of about 41,567 (239)
Some of the next articles are maybe not open access.

Cholinesterase inhibitors for Alzheimer's disease

Cochrane Database of Systematic Reviews, 2006
Since the introduction of the first cholinesterase inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, donepezil, galantamine and rivastigmine, to be the first line pharmacotherapy for mild to moderate Alzheimer's disease.The drugs have slightly different pharmacological properties, but they all ...
openaire   +2 more sources

Cholinesterase Inhibitors

2011
Andrew E. Budson, Paul R. Solomon
openaire   +2 more sources

Cholinesterase Inhibitors for Alzheimer's Disease

Hospital Practice, 1998
New cholinesterase inhibitors capable of slowing the progression of Alzheimer's disease are being introduced at a rapid pace. In prescribing these drugs and setting realistic expectations for outcome, it is necessary to understand that they affect cholinergic activity in other tissues as well as the brain.
openaire   +2 more sources

Cholinesterase Inhibitors

2015
Nir Waiskopf, Hermona Soreq
openaire   +2 more sources

Cholinesterase Inhibitors

2017
Pamela E. Potter, Laszlo Kerecsen
openaire   +1 more source

Cholinesterase Inhibitors

2007
Jeffrey Kao, George Grossberg
openaire   +1 more source

Cholinesterase Inhibitors

2010
Daniel Hoyer   +199 more
openaire   +1 more source

Home - About - Disclaimer - Privacy